Literature DB >> 20542331

pH-Dependent biodegradable silica nanotubes derived from Gd(OH)3 nanorods and their potential for oral drug delivery and MR imaging.

Kuo-Wei Hu1, Kang-Che Hsu, Chen-Sheng Yeh.   

Abstract

We report a pH dependence of degradable silica nanotubes, which dissolved to the biodegradation product monosilicic acid, Si(OH)(4). The silica nanotubes, potentially acting as oral-based administration carriers, were resistant to dissolution in the extreme acidic condition of pH 1, but degraded quickly at pH 8, and the degradation rate can be tuned by tailoring the thickness of silica nanotubes with thicker nanotubes dissolving more slowly. Because Gd(OH)(3) nanorods were used as templates, the silica nanotubes could be further developed as MR imaging contrast agents as well as drugs carriers. The released Gd(3+) ions resulting from the etching of Gd(OH)(3) nanorods were chelated by the pre-modified DOTA, yielding Gd-DOTA complexes grafted onto silica nanotubes. The Gd-DOTA grafted silica nanotubes loaded with doxorubicin revealed enhanced T(1) imaging contrast and anticancer activity. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542331     DOI: 10.1016/j.biomaterials.2010.05.046

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

1.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

2.  Synthesis of water-degradable silica nanoparticles from carbamate-containing bridged silsesquioxane precursor.

Authors:  Zhe Gao; Seyyed Pouya Hadipour Moghaddam; Hamidreza Ghandehari; Ilya Zharov
Journal:  RSC Adv       Date:  2018-01-29       Impact factor: 4.036

3.  Hexagonal hollow silica plate particles with high transmittance under ultraviolet-visible light.

Authors:  Lailatul Qomariyah; Aditya F Arif; W Widiyastuti; Sugeng Winardi; Shuto Taniguchi; Takashi Ogi
Journal:  RSC Adv       Date:  2018-07-23       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.